Pi Health is to deliver outsourced clinical research services in a GSK oncology study to enhance the efficiency and speed of ...

Bayer vice president Luiz Barberini explains how the German giant’s cooperation with suppliers fosters long-term trial ...

On 24 September, uniQure announced positive topline results from its pivotal Phase I/II studies (HD-GENE-TRX1, HD-GENE-TRX2) ...

As China's biotech sector continues to buzz with innovation, the country is rapidly integrating into the global clinical ...

Datavant has partnered with life sciences commercialisation firm Indegene to enhance recruitment of subjects for clinical ...

AstraZeneca’s Saphnelo (SC) administration has shown a decrease in disease activity in individuals with systemic lupus ...

PepGen’s stock has risen by over 120% after its investigational myotonic DM1 candidate reported the highest mean splicing correction in a Phase I trial.

Nektar Therapeutics has presented data of its atopic dermatitis (AD) candidate rezpeg (rezpegaldesleukin), which sent the ...

REDCap Cloud (nPhase) has introduced a new platform to unify real-world evidence with clinical study data within a single ...

The main concerns about tariffs that businesses have are higher input costs and uncertainty in long-term planning.

Trially has raised $4.7m in a seed funding round and introduced its agentic AI solution, Margo, designed to increase study ...

The Alzheimer’s disease market is expected to grow at a high compound annual growth rate (CAGR) of 21.8% from $2.4bn in 2023 to $17bn by 2033. Image credit: Antonio Marca / Shutterstock.com Eli Lilly ...